Sunday, Nov 22, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Business | Zenara Gets Cdsco Approval To Make Covid Drug

Zenara gets CDSCO approval to make Covid drug

Hyderabad: Hyderabad-based Zenara Pharma, a fully owned subsidiary of Biophore India Pharmaceuticals, has announced that it has received approval from the Central Drugs Standard Control Organization (CDSCO) to manufacture and market Nirmatrelvir and Ritonavir tablets in a combi pack as a treatment option for patients with mild to moderate symptoms of Covid-19 in adults. The […]

By Telangana Today
Published Date - 28 July 2022, 05:54 PM
Zenara gets CDSCO approval to make Covid drug
whatsapp facebook twitter telegram

Hyderabad: Hyderabad-based Zenara Pharma, a fully owned subsidiary of Biophore India Pharmaceuticals, has announced that it has received approval from the Central Drugs Standard Control Organization (CDSCO) to manufacture and market Nirmatrelvir and Ritonavir tablets in a combi pack as a treatment option for patients with mild to moderate symptoms of Covid-19 in adults.

The tablet, which will be sold under the brand name ‘Paxzen’, is being manufactured at Zenara’s US FDA approved facility in Hyderabad. This approval by the CDSCO has been granted under the emergency authorization route considering the unmet medical need in Covid-19 for an effective and affordable therapy for the patients in India.


“We believe Paxzen is an effective treatment option against Covid-1. Is a complex product to develop and manufacture. We have brought this product to the market in record time and this is one of the first approvals of this product in India. We have our own in-house API and are not dependent on any imports for the production. This will ensure stability and rapid production and availability of this treatment for the Indian market,” said Dr Jagadeesh Babu Rangisetty, Co-founder and Managing Director at Zenara Pharma.

The product got the USFDA approval in December 2021. It was the first oral pill that has been approved by USFDA and with a better safety profile than subsequently approved oral therapies.
“We expect to launch Paxzen in the next couple of weeks and are in talks with multiple institutions and several hospitals in India to ensure that the product is readily available for patients in need. We are also likely to tie up with other partners across the country to increase patient coverage and have been inviting discussions on the same,” said Dr Srinivas Arutla, CEO, Zenara Pharma. Zenara’s product portfolio consists of tablets and capsules with capabilities to manufacture oral solutions as well, a release said.

Join Our Whatsapp Channel
  • Follow Us :
As preferred source
  • Tags
  • Covid-19
  • Nirmatrelvir
  • Ritonavir tablets
  • Zenara Pharma

Related News

  • Harish asks BRSV to highlight govt’s failure to release fee reimbursement funds

    Harish asks BRSV to highlight govt’s failure to release fee reimbursement funds

  • Odisha reports two new COVID-19 cases, total infections rise to three

    Odisha reports two new COVID-19 cases, total infections rise to three

  • Four Covid-19 patients under treatment in Kolkata as doctors urge vigilance

    Four Covid-19 patients under treatment in Kolkata as doctors urge vigilance

  • Post-Covid steroid use linked to rising hip arthritis among young adults

    Post-Covid steroid use linked to rising hip arthritis among young adults

Latest News

  • Women in Hyderabad’s crime networks: Police cite cases of extortion and trespass

    22 minutes ago
  • Leopard attempts to attack farmer in Vikarabad’s Naskal village

    37 minutes ago
  • KNRUHS reopens BHMS Management Quota applications for 2026-27

    38 minutes ago
  • AIASCT to launch nationwide black badge programme from November 23

    38 minutes ago
  • Nearly 800 children take part in Hyderabad Kids Run 2026

    2 hours ago
  • Hyderabad: Krishna Kanth Park visitors seek sanitation fixes, better facilities during HYDRAA chief’s visit

    37 minutes ago
  • TGSRTC saves Rs 36 crore in diesel costs using i-ALERT technology in 1,500 buses

    36 minutes ago
  • Rashmika Mandanna’s ‘Mysaa’ postponed five days before November 27 release; new date awaited

    1 hour ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam

Telangana Today App